WBA Walgreens Boots Alliance Inc

$11.98

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Walgreens Boots Alliance's upcoming earnings report on June 26, 2025, is set against a backdrop of strategic shifts and financial challenges, with the company's market cap standing at approximately $9.87 billion. Notably, the whisper number of $0.40 per share suggests a cautious optimism among investors, slightly above the EPS estimate of $0.33. This comes after a turbulent fiscal year marked by a significant net loss in Q1 2025, driven by store closures and opioid litigation costs. Despite these hurdles, Walgreens has shown resilience in its international operations, with steady growth in the Germany wholesale business and Boots UK sales. However, the U.S. Retail Pharmacy segment continues to face headwinds, impacting overall profitability. Analysts are closely watching the company's ability to navigate these challenges while maintaining revenue growth, projected at $36.84 billion for the quarter. As Walgreens transitions towards a potential acquisition by Sycamore Partners, the market remains attentive to how these developments will influence future earnings and strategic direction.

Updated On 1/6/2026

About Walgreens Boots Alliance Inc

Walgreens Boots Alliance, Inc. is an American pharmaceuticals holding company headquartered in Deerfield, Illinois. It owns the pharmacy chains Walgreens and Boots, as well as several pharmaceutical manufacturing, wholesale, and distribution companies.

Website: https://www.walgreensbootsalliance.com

Sector
TRADE & SERVICES
Industry
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
August
CIK
1618921
Address
108 WILMOT ROAD, DEERFIELD, IL, US
Valuation
Market Cap
$9.42B
P/E Ratio
nan
PEG Ratio
3.55
Price to Book
1.32
Performance
EPS
$-6.69
Dividend Yield
9.18%
Profit Margin
-3.80%
ROE
-66.20%
Technicals
50D MA
$10.80
200D MA
$10.17
52W High
$17.60
52W Low
$7.98
Fundamentals
Shares Outstanding
865M
Target Price
$12.29
Beta
0.64

WBA EPS Estimates vs Actual

Estimated
Actual

WBA News & Sentiment

Dec 30, 2025 • MarketBeat SOMEWHAT-BULLISH
Pacer Advisors Inc. Sells 880,384 Shares of Cencora, Inc. $COR
Pacer Advisors Inc. significantly reduced its stake in Cencora (NYSE:COR) by 97.8%, selling 880,384 shares in Q3, but still holds 20,187 shares valued at $6.31 million. Insiders EVP Silvana Battaglia and CEO Robert P. Mauch also sold shares in December, totaling 20,317 shares worth approximately $7.01 million over the last three months, though insiders still own 10.8% of the company. Wall Street analysts maintain a "Moderate Buy" rating with a consensus target price of $373.25, with some firms raising their price targets after Cencora reported strong Q3 earnings and increased its dividend.
Dec 30, 2025 • AD HOC NEWS NEUTRAL
CVS Health Corp.: Dividend Doubts, Strategy Shifts and a Market Struggling to Believe
CVS Health Corp. is facing investor skepticism as its stock slides amidst a pivot to value-based care, concerns over dividend stability, and mixed Wall Street signals. Despite a comprehensive strategy involving retail pharmacies, PBM, insurance, and newly acquired primary and home-care assets, the market remains unconvinced by the long-term transformation given execution risks and reimbursement pressures. While the company's valuation underpins a contrarian bull case due to a defensive model and strong cash flows, the market demands tangible evidence of margin protection and synergy harvesting to shift the bearish sentiment.
Dec 28, 2025 • MarketBeat NEUTRAL
Sapient Capital LLC Decreases Holdings in MercadoLibre, Inc. $MELI
Sapient Capital LLC reduced its stake in MercadoLibre, Inc. (NASDAQ:MELI) by 7.3% in the third quarter of 2025, selling 1,583 shares and ending the period with 20,206 shares valued at $50.34 million. The company's third-quarter earnings per share of $8.32 missed analyst estimates, though revenue grew by 39.5% year-over-year to $7.41 billion, exceeding expectations. Institutional investors hold 87.62% of MercadoLibre's stock, and analysts currently have a "Moderate Buy" rating with an average target price of $2,842.94.
Dec 27, 2025 • MarketBeat SOMEWHAT-BULLISH
Cwm LLC Has $75.20 Million Stock Position in Eli Lilly and Company $LLY
Cwm LLC significantly increased its stake in Eli Lilly and Company by 11.1% in Q3, now holding 98,555 shares valued at $75.20 million. Eli Lilly reported a strong quarter with earnings beating estimates and raised its FY2025 EPS guidance, alongside increasing its quarterly dividend. The stock currently has a "Moderate Buy" consensus rating from analysts, with several firms raising price targets due to positive new drug data and financial performance.
Dec 24, 2025 • Star-Gazette NEUTRAL
These stores will be open, closed on Christmas in Elmira, Corning, Hornell
This article provides a comprehensive guide to the Christmas Eve, Christmas Day, New Year's Eve, and New Year's Day hours for major grocery and drug stores in the Elmira, Corning, and Hornell areas. It details the specific schedules for Wegmans, Walmart, Tops, Aldi, CVS, and Walgreens, noting which will be closed and which will operate with reduced hours during the holidays.
Dec 24, 2025 • NBC 5 Dallas-Fort Worth NEUTRAL
Here's what stores are open, and which ones are closed, on Christmas
This article provides a comprehensive list of major retailers and grocery stores that will be open or closed on Christmas Day. It advises readers to check local hours online or call ahead, as operating times can vary by location. The list includes giants like Walmart, Target, Costco, CVS, Walgreens, Starbucks, McDonald's, Kroger, and Albertsons, along with many others.
Sentiment Snapshot

Average Sentiment Score:

0.033
50 articles with scored sentiment

Overall Sentiment:

Neutral

WBA Reported Earnings

Apr 03, 2025
Feb 28, 2025 (Pre market)
-3.83 Surprise
  • Reported EPS: $-3.30
  • Estimate: $0.53
  • Whisper:
  • Surprise %: -722.6%
Jan 02, 2025
Nov 30, 2024 (Pre market)
0.12 Surprise
  • Reported EPS: $0.51
  • Estimate: $0.39
  • Whisper:
  • Surprise %: 30.8%
Oct 10, 2024
Aug 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $0.39
  • Estimate: $0.36
  • Whisper:
  • Surprise %: 8.3%
Jun 27, 2024
May 31, 2024 (Pre market)
-0.05 Surprise
  • Reported EPS: $0.63
  • Estimate: $0.68
  • Whisper:
  • Surprise %: -7.3%
Mar 28, 2024
Feb 29, 2024 (Pre market)
0.38 Surprise
  • Reported EPS: $1.20
  • Estimate: $0.82
  • Whisper:
  • Surprise %: 46.3%
Jan 04, 2024
Nov 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.66
  • Estimate: $0.61
  • Whisper:
  • Surprise %: 8.2%
Oct 12, 2023
Aug 31, 2023 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.67
  • Estimate: $0.69
  • Whisper:
  • Surprise %: -2.9%
Jun 27, 2023
May 31, 2023 (Pre market)
-0.07 Surprise
  • Reported EPS: $1.00
  • Estimate: $1.07
  • Whisper:
  • Surprise %: -6.5%
Mar 28, 2023
Feb 28, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $1.16
  • Estimate: $1.10
  • Whisper:
  • Surprise %: 5.5%

Financials